Worldwide Rising Diabetes Population and Related Disorders to Drive Continuous Glucose Monitoring Market to USD 1.2 Billion by 2020 - iHealthcareAnalyst, Inc.

Maryland Heights, MO, August 21, 2016 --(PR.com)-- According to a new market research report published by iHealthcareAnalyst, Inc., Continuous Glucose Monitoring Market 2013-2020, the global continuous glucose monitoring market is estimated to reach USD 1.2 Billion in 2020, expanding at a CAGR of 16.1% from 2016 to 2020.

Visit the Continuous Glucose Monitoring Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/continuous-glucose-monitoring-market/

The global continuous glucose monitoring market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

Continuous glucose monitoring (CGM) is a small wearable device that tracks blood glucose throughout the day and night, notifying the highs and lows in order to take better treatment decisions and better glucose control. CGM helps to minimize the guesswork that comes from making decisions based solely on a number from a blood glucose meter reading, for better diabetes management.

The global continuous glucose monitoring market segmentation is based on product types (Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System). The global continuous glucose monitoring market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global continuous glucose monitoring market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Device Type
1.1. Dexcom G4 Platinum
1.2. Dexcom Seven Plus CGM System
1.3. FreeStyle Navigator
1.4. Guardian Real Time CGM System
1.5. MiniMed Paradigm Revel/Veo System
1.6. Others

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Abbott Laboratories
3.2. Bayer AG
3.3. Dexcom, Inc.
3.4. GlySens Incorporated
3.5. Insulet Corporation
3.6. Medtronic, Inc.
3.7. Nova Biomedical Corporation
3.8. Senseonics, Incorporated

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com

Website: http://www.ihealthcareanalyst.com